These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12774774)

  • 61. Musculoskeletal manifestations of Fabry disease: A retrospective study.
    Lidove O; Zeller V; Chicheportiche V; Meyssonnier V; Sené T; Godot S; Ziza JM
    Joint Bone Spine; 2016 Jul; 83(4):421-6. PubMed ID: 26697993
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Fabry disease].
    Kantola I; Penttinen M; Nuutila P; Viikari J
    Duodecim; 2012; 128(7):729-39. PubMed ID: 22612023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease.
    Hughes DA; Malmenäs M; Deegan PB; Elliott PM; Ginsberg L; Hajioff D; Ioannidis AS; Orteu CH; Ramaswami U; West M; Pastores GM; Jenkinson C;
    J Med Genet; 2012 Mar; 49(3):212-20. PubMed ID: 22315436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.
    Whybra C; Kampmann C; Willers I; Davies J; Winchester B; Kriegsmann J; Brühl K; Gal A; Bunge S; Beck M
    J Inherit Metab Dis; 2001 Dec; 24(7):715-24. PubMed ID: 11804208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bone and joint involvement in Fabry disease.
    Sacre K; Lidove O; Giroux Leprieur B; Ouali N; Laganier J; Caillaud C; Papo T
    Scand J Rheumatol; 2010 Mar; 39(2):171-4. PubMed ID: 20001766
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry.
    Sims K; Politei J; Banikazemi M; Lee P
    Stroke; 2009 Mar; 40(3):788-94. PubMed ID: 19150871
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.
    Zampetti A; Orteu CH; Antuzzi D; Bongiorno MR; Manco S; Gnarra M; Morrone A; Cardinali G; Kovacs D; Aspite N; Linder D; Parini R; Feliciani C;
    Br J Dermatol; 2012 Apr; 166(4):712-20. PubMed ID: 22452439
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Results of an ophthalmologic screening programme for identification of cases with Anderson-Fabry disease.
    Hauser AC; Lorenz M; Voigtländer T; Födinger M; Sunder-Plassmann G
    Ophthalmologica; 2004; 218(3):207-9. PubMed ID: 15103218
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enzyme replacement therapy for Fabry disease, an inherited nephropathy.
    Desnick RJ; Banikazemi M; Wasserstein M
    Clin Nephrol; 2002 Jan; 57(1):1-8. PubMed ID: 11837797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Significance of screening for Fabry disease among male dialysis patients.
    Ichinose M; Nakayama M; Ohashi T; Utsunomiya Y; Kobayashi M; Eto Y
    Clin Exp Nephrol; 2005 Sep; 9(3):228-32. PubMed ID: 16189631
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin.
    Pisani A; Riccio E; Cianciaruso B; Imbriaco M
    J Nephrol; 2011; 24(6):806-8. PubMed ID: 22058028
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myeloid bodies in patients without clinical Fabry's disease.
    McNamara TE; Goodloe S; Butkus DE
    Arch Pathol Lab Med; 1980 Jan; 104(1):14-6. PubMed ID: 6243209
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of lymphedema among Anderson-Fabry disease patients: A report from the Fabry registry.
    Alkhatib D; Vega JA; Pour-Ghaz I; Al-Taweel O; Khan S; DeCarr K; Bath A; Rawal A; Wilbanks D; Raja J; Butt A; Yedlapati N; Hopkin RJ; Jefferies JL
    Mol Genet Metab; 2023 Apr; 138(4):107538. PubMed ID: 36812723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Phase 2 study of migalastat hydrochloride in females with Fabry disease: selection of population, safety and pharmacodynamic effects.
    Giugliani R; Waldek S; Germain DP; Nicholls K; Bichet DG; Simosky JK; Bragat AC; Castelli JP; Benjamin ER; Boudes PF
    Mol Genet Metab; 2013 May; 109(1):86-92. PubMed ID: 23474038
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].
    Lidove O; Bekri S; Goizet C; Khau Van Kien A; Aractingi S; Knebelmann B; Choukroun G; Tsimaratos M; Redonnet-Vernhet I; Lacombe D; Jaussaud R
    Presse Med; 2007; 36(7-8):1084-97. PubMed ID: 17276649
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A family with a rare disease].
    Capelo J; Soares C; Carragoso A; Ribeiro P; Girão F; Henriques P
    Acta Med Port; 2010; 23(3):499-504. PubMed ID: 20654270
    [TBL] [Abstract][Full Text] [Related]  

  • 77. alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease.
    Linthorst GE; Hollak CE; Korevaar JC; Van Manen JG; Aerts JM; Boeschoten EW
    Nephrol Dial Transplant; 2003 Aug; 18(8):1581-4. PubMed ID: 12897098
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renal disease in Fabry patients.
    Grünfeld JP; Lidove O; Joly D; Barbey F
    J Inherit Metab Dis; 2001; 24 Suppl 2():71-4; discussion 65. PubMed ID: 11758682
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fabry disease: a review.
    Masson C; Cissé I; Simon V; Insalaco P; Audran M
    Joint Bone Spine; 2004 Sep; 71(5):381-3. PubMed ID: 15474388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.
    Ries M; Ramaswami U; Parini R; Lindblad B; Whybra C; Willers I; Gal A; Beck M
    Eur J Pediatr; 2003 Nov; 162(11):767-72. PubMed ID: 14505049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.